EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Credit Rating Analysis
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ Maruto Sangyo
@ Carna Biosciences
@ 小野産業
@ HABA LABORATORIES
@ New Japan Chemical
@ 廣貫堂
@ KOEI CHEMICAL
@ 日本化学工業
@ Kawaguchi Chemical Industry
@ Nippon Shikizai
@ ダイトーケミックス
@ LTT Bio-Pharma
@ TAIHEI CHEMICALS
@ TAOKA CHEMICAL
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
10/30 Real Estate (DAIBIRU:BBB→A e..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
Hitachi Zosen etc.
graph
NIPPON COKE & ENGINEERING
graph
メルコホールディングス
graph
ROHM
graph
日本セラミック etc.
graph

Credit Rating Analysis: ダイトーケミックス (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk): ダイトーケミックス (Annual ) Consolidated | Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2013-03-31  CC  Credit is very vulnerable. ¥ 8 B
-26.61%
¥ -886 M
-803.17%
¥ -1 B
-915.97%

Financial Timeline

Date  2012-12-31 
(Third quarter )
 2013-03-31 
(Annual )
 2013-06-30 
(First quarter )
 2013-09-30 
(Second quarter )
Credit Rating CCCCCB
Total Assets
¥ 12 B
¥ 12 B
¥ 12 B
¥ 12 B
Net Assets
¥ 8 B
¥ 8 B
¥ 7 B
¥ 8 B

Financial Statement Risk Analysis: ダイトーケミックス (Annual ) (Consolidated )

Special note
The change of Net income is going too far. The management situation is unstable.
[Date: 2013-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income & Sales is sharp decrease )
As compared with the first term of Sales (¥ 8 B) , Sales (¥ 11 B) is less than 80%, and As compared with the first term of Net Income (¥ 169 M) , Net Income (¥ -1 B) is less than 10%, , there is a possibility that the management situation has deteriorated very much.
Management Risk (*Sales is decrease )
Sales (¥ 8 B) is first term Sales (¥ 11 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Income is decrease )
Net Income (¥ -1 B) is first term Net Income (¥ 169 M) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-16.40%) is first term Net Profit Margin (1.47%) less , there is a possibility that the profitability has deteriorated.
Dividend Risk
Under the situation of Net Income (¥ -1 B) & Operating Cash Flow (¥ 18 M), Dividend (¥ -43 M) is paid.
Financing Risk (*Interest-bearing Debt more)
Sales first term ratio (¥ -3 B) & Operating Cash Flow first term ratio (¥ -290 M) is a minus, Interest-bearing Debt (¥ 3 B) is first term Interest-bearing Debt (¥ 3 B) more , there is a possibility that the financing has deteriorated very much.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ -1 B) is Sales first term ratio (¥ -3 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2012-03-31]  Danger : Warning : Caution : Good
Management Risk (*Sales is decrease )
Sales (¥ 11 B) is first term Sales (¥ 12 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Gross Income is decrease )
Gross Income (¥ 10 B) is first term Gross Income (¥ 11 B) less , there is a possibility that the management situation has stagnated and deteriorated
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -223 M) & Financial Cash Flow (¥ -645 M) is a minus, Operating Cash Flow (¥ 308 M) is a plus,
Dividend
Under the situation of Net Income (¥ 169 M) & Operating Cash Flow (¥ 308 M) , Dividend (¥ -21 M) is paid.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 530 M) is Sales first term ratio (¥ -999 M) more , there is a possibility that the non-performing asset was increased.
[Date: 2011-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is severe.
Management Risk (*Net Income is decrease )
Net Income (¥ -1 B) is first term Net Income (¥ -874 M) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-12.73%) is first term Net Profit Margin (-7.08%) less , there is a possibility that the profitability has deteriorated.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -1 B) & Financial Cash Flow (¥ -754 M) is a minus, Operating Cash Flow (¥ 861 M) is a plus,
Dividend Risk
Under the situation of Net Income (¥ -1 B) & Operating Cash Flow (¥ 861 M), Dividend (¥ -54 M) is paid.
Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 12 B) is first term (¥ 12 B) more, however Operating Cash Flow (¥ 861 M) is first term (¥ 1 B) less , there is a possibility that the financing has deteriorated very much.
Overinvestment Risk (*Investment Cash Flow confirmed content)
Net Income (¥ -1 B) is a minus, the cashflow of Operating Cash Flow (¥ 861 M) is smaller than Investment Cash Flow (¥ -1 B) , there is a possibility of the overinvestment.
[Date: 2010-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -874 M) is minus or 0, so , there is a possibility that the management situation is severe.
Management Risk (*Sales is decrease )
Sales (¥ 12 B) is first term Sales (¥ 12 B) less , there is a possibility that the management situation has stagnated and deteriorated
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -1 B) & Financial Cash Flow (¥ -299 M) is a minus, Operating Cash Flow (¥ 1 B) is a plus,
Dividend Risk
Under the situation of Net Income (¥ -874 M) & Operating Cash Flow (¥ 1 B), Dividend (¥ -65 M) is paid.
Overinvestment Risk (*Investment Cash Flow confirmed content)
Net Income (¥ -874 M) is a minus, the cashflow of Operating Cash Flow (¥ 1 B) is smaller than Investment Cash Flow (¥ -1 B) , there is a possibility of the overinvestment.
[Date: 2009-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is severe.
Dividend Risk
Under the situation of Net Income (¥ -1 B) & Operating Cash Flow (¥ 588 M), Dividend (¥ -87 M) is paid.
Overinvestment Risk (*Investment Cash Flow confirmed content)
Net Income (¥ -1 B) is a minus, the cashflow of Operating Cash Flow (¥ 588 M) is smaller than Investment Cash Flow (¥ -987 M) , there is a possibility of the overinvestment.

Related Information: ダイトーケミックス (Annual )

Statement Type
Annual : ダイトーケミックス
First quarter : ダイトーケミックス
Second quarter : ダイトーケミックス
Third quarter : ダイトーケミックス
Analysis Menu
@Outline : ダイトーケミックス
@Statement : ダイトーケミックス
@Rating : ダイトーケミックス
@Indicator : ダイトーケミックス
@Download : ダイトーケミックス
Industry Comparison Ranking
Chemicals - EDIUNET Industry Rankings
Chemicals - EDIUNET Credit Rating
Chemicals - EDIUNET Industry Avg
Comparison with a neighboring company
Osaka - EDIUNET Prefectures
Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/23 Milbon AA→AAA 2013-12-20
1/17 Kawaguchi Chemical Indu.. BBB→BB 2013-11-30
1/17 SANKEI CHEMICAL A 2013-11-30
1/15 HOKKO CHEMICAL INDUSTRY BB→B 2013-11-30
1/15 Daito Pharmaceutical Co . AA 2013-11-30 (Q2)
1/15 KAWAKAMI PAINT MFG. B→BB 2013-11-30
1/15 旭化学工業 AA 2013-11-30 (Q1)
1/10 OSAKA ORGANIC CHEMICAL .. BB→BBB 2013-11-30
1/10 HISAMITSU PHARMACEUTICAL A 2013-11-30 (Q3)
1/10 AMS Life Science BBB→BB 2013-11-30 (Q1)

Ticker Market Industry Month report Rating
@ ダイトーケミックス 4366 TSE 2st Chemicals 3 Annual CC

Related Company

@ ダイトーケミックス (Sales ¥ 8 B)
@ TAIHEI CHEMICALS (Sales ¥ 5 B)
@ 廣貫堂 (Sales ¥ 13 B)
@ 小野産業 (Sales ¥ 3 B)
@ LTT Bio-Pharma (Sales ¥ 61 M)
@ 日本化学工業 (Sales ¥ 32 B)
@ Nippon Shikizai (Sales ¥ 7 B)
@ Carna Biosciences (Sales ¥ 510 M)
@ TAOKA CHEMICAL (Sales ¥ 17 B)
@ New Japan Chemical (Sales ¥ 28 B)
@ Kawaguchi Chemical Industry (Sales ¥ 6 B)
@ HABA LABORATORIES (Sales ¥ 13 B)
@ KOEI CHEMICAL (Sales ¥ 18 B)
Sponsored Link


関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (2.186 sec.)